Fibromyalgia news from FiercePharma
NewsPfizer's Lyrica booms on iffy diagnosis
Is fibromyalgia an ill-gotten label that could only benefit drug companies? Or is it a real disease that needs treatment? Judging by the abrupt rise in prescriptions for the Pfizer drug Lyrica
Northwestern sells Lyrica rights for $700M
It's the last big Lyrica bonanza for Northwestern University. The school sold part of its royalty rights to the blockbuster drug for $700 million. That's a big chunk of change--and this after several... Read more...
Lilly pursues new Cymbalta approval
What do you do with a booming antidepressant? Broaden its scope, of course. Eli Lilly has filed for FDA approval to sell Cymbalta as a fibromyalgia remedy. It's already marketed for use against... Read more...
| Press ReleasesJAZZ PHARMACEUTICALS, INC. ANNOUNCES FINAL PATIENT HAS COMPLETED PHASE III CLINICAL TRIAL OF SODIUM OXYBATE TO TREAT FIBROMYALGIJAZZ PHARMACEUTICALS, INC. ANNOUNCES FINAL PATIENT HAS COMPLETED PHASE III CLINICAL TRIAL OF SODIUM OXYBATE TO TREAT FIBROMYALGIA PALO ALTO, Calif., Sept. 11 -- Jazz Pharmaceuticals, Inc. (Nasdaq: Read more >> PRESS RELEASE: Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show NEW YORK, Nov. 8 -- Total daily dosages of milnacipran 100 mg and 200 mg Read more >> PRESS RELEASE: Sosei Drug Misses Goal in Fibromyalgia Trial Sosei Drug Misses Goal in Fibromyalgia Trial TOKYO, September 18 -- Sosei Group Corporation , the biopharmaceutical company, today announces that AD 337, an enantiomer of an approved, centrally Read more >> |
Get more Fibromyalgia coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
